SCHEMBL7370567

SCHEMBL7370567

N#Cc1cccc(Oc2ncccc2C(=O)NCc2ccc(S(N)(=O)=O)cc2)c1

nearest known ligand 0.78

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 2/20 0.56
KMT2A Q03164 2/20 0.48
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
AURKA O14965 1/20 0.47
ROCK2 O75116 1/20 0.47
CSF1R P07333 1/20 0.47
RPS6KB1 P23443 1/20 0.47
MAPK1 P28482 1/20 0.47
AKT1 P31749 1/20 0.47
MAPK9 P45984 1/20 0.47
CSNK1D P48730 1/20 0.47
PRKD2 Q9BZL6 1/20 0.47
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7369360 0.86 MAPK8 (0.57) MAPK8KMT2ACA2CA4HPGD
SCHEMBL7367173 0.86 KMT2A (0.60) MAPK8KMT2ACA2CA4HPGD
SCHEMBL7368824 0.84 MAPK8 (0.64) MAPK8KMT2ACA2HPGDLMNA
SCHEMBL7370447 0.84 MAPK8 (0.56) MAPK8KMT2AADRA2AADRA2BADRA2C
SCHEMBL7680876 0.82 MAPK8 (0.54) MAPK8KMT2AADRA2AADRA2BADRA2C
SCHEMBL7373102 0.81 MAPK8 (0.53) MAPK8KMT2AADRA2AADRA2BADRA2C
SCHEMBL7371159 0.81 MAPK8 (0.62) MAPK8KMT2AHPGDLMNASMN1; SMN2
SCHEMBL922045 0.80 MAPK8 (0.50) MAPK8HPGDLMNASMN1; SMN2
SCHEMBL7364427 0.80 MAPK8 (0.52) MAPK8KMT2ACA2CA4HPGD
SCHEMBL6579096 0.79 ALDH1A1 (0.50) MAPK8ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380218-B1 FOR THERAPY OF RESPIRATORY, ALLERGIC, AND INFLAMMATORY DISORDERS COMPRISING ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ACUTE RESPIRATORY DISEASE SYNDROME, PULMONARY HYPERSENSITIVITY, AND ALLERGIC RHINITIS IN A MAMMAL PFIZER INC 2002-04-30 US disclosed
EP-0971894-A1 NICOTINAMIDE DERIVATIVES Pfizer Products Inc. (US) 2000-01-19 EP disclosed
WO-1998045268-A1 NICOTINAMIDE DERIVATIVES PFIZER PRODUCTS INC. (US) 1998-10-15 WO disclosed